117 related articles for article (PubMed ID: 35818932)
41. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
42. Nano-delivery of
Saadat N; Liu F; Haynes B; Nangia-Makker P; Bao X; Li J; Polin LA; Gupta S; Mao G; Shekhar MP
Mol Cancer Ther; 2018 Dec; 17(12):2586-2597. PubMed ID: 30242094
[TBL] [Abstract][Full Text] [Related]
43. Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer.
Taurin S; Nehoff H; Diong J; Larsen L; Rosengren RJ; Greish K
J Drug Target; 2013 Aug; 21(7):675-83. PubMed ID: 23679865
[TBL] [Abstract][Full Text] [Related]
44. pH-Sensitive micelles with mitochondria-targeted and aggregation-induced emission characterization: synthesis, cytotoxicity and biological applications.
Li J; Liu Y; Li H; Shi W; Bi X; Qiu Q; Zhang B; Huang W; Qian H
Biomater Sci; 2018 Nov; 6(11):2998-3008. PubMed ID: 30259038
[TBL] [Abstract][Full Text] [Related]
45. Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models.
Chen W; Li L; Zhang X; Liang Y; Pu Z; Wang L; Mo J
Drug Deliv; 2017 Nov; 24(1):1470-1481. PubMed ID: 28956452
[TBL] [Abstract][Full Text] [Related]
46. Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells.
Hu J; Obayemi JD; Malatesta K; Košmrlj A; Soboyejo WO
Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():32-45. PubMed ID: 29636136
[TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
[TBL] [Abstract][Full Text] [Related]
48. [Preparation of curcumin TPP-PEG-PE nanomicelles with mitochondrial targeting and lysosomal escape functions and its effect on promoting breast cancer cell apoptosis].
Yin-Hua Y; Qi G; Shan-Shan Z; Mi T
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5495-5503. PubMed ID: 33350211
[TBL] [Abstract][Full Text] [Related]
49. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
[TBL] [Abstract][Full Text] [Related]
50. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
[TBL] [Abstract][Full Text] [Related]
51. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
[TBL] [Abstract][Full Text] [Related]
52. Anisomycin inhibits angiogenesis, growth, and survival of triple-negative breast cancer through mitochondrial dysfunction, AMPK activation, and mTOR inhibition.
Yang W; Zhou C; Sun Q; Guan G
Can J Physiol Pharmacol; 2022 Jul; 100(7):612-620. PubMed ID: 35852219
[TBL] [Abstract][Full Text] [Related]
53. Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy.
Wang Y; Wang Y; Chen G; Li Y; Xu W; Gong S
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30297-30305. PubMed ID: 28845963
[TBL] [Abstract][Full Text] [Related]
54. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
[TBL] [Abstract][Full Text] [Related]
55. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
[TBL] [Abstract][Full Text] [Related]
56. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
[TBL] [Abstract][Full Text] [Related]
57. Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging.
Jugniot N; Massoud TF; Dahl JJ; Paulmurugan R
J Nanobiotechnology; 2022 Jun; 20(1):267. PubMed ID: 35689262
[TBL] [Abstract][Full Text] [Related]
58. Combined Shikonin-Loaded MPEG-PCL Micelles Inhibits Effective Transition of Endothelial-to-Mesenchymal Cells.
Li G; Shang C; Li Q; Chen L; Yue Z; Ren L; Yang J; Zhang J; Wang W
Int J Nanomedicine; 2022; 17():4497-4508. PubMed ID: 36186533
[TBL] [Abstract][Full Text] [Related]
59. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.
Yang YY; Zhang W; Liu H; Jiang JJ; Wang WJ; Jia ZY
Drug Des Devel Ther; 2021; 15():4961-4972. PubMed ID: 34916779
[TBL] [Abstract][Full Text] [Related]
60. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
